Results 221 to 230 of about 1,213,487 (359)

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients [PDF]

, 2011
Francesca Gay, Alessandra Larocca, Pierre W. Wijermans, Federica Cavallo, Davide Rossi, Ron Schaafsma, Mariella Genuardi, Alessandra Romano, Anna Marina Liberati, Agostina Siniscalchi, Maria Teresa Petrucci, Chiara Nozzoli, Francesca Patriarca, Massimo Offidani, Roberto Ria, Paola Omedè, Benedetto Bruno, Roberto Passera, Pellegrino Musto, Mario Boccadoro, Pieter Sonneveld, Antonio Palumbo   +21 more
openalex   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

Stereotactic body radiation therapy in oligometastatic pancreatic cancer: overall survival improvement and <i>SMAD4</i> as a predictor of progression-free survival. [PDF]

J Gastrointest Oncol
Elhariri A, Patel J, Mahadevia H, Modi K, Albelal D, Majeed U, Jones JC, Borad MJ, Tran NH, Rutenberg MS, Babiker H.   +10 more
europepmc   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

A CT-based radiomics model for predicting progression-free survival in patients with epithelial ovarian cancer. [PDF]

BMC Cancer
Leng Y, Zhou J, Liu W, Luo F, Peng F, Gong L.   +5 more
europepmc   +1 more source

For Children with High-Risk Neuroblastoma, Immunotherapy Extends Progression-Free Survival

, 2009
Charlene Laino
openalex   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

Analysis of factors influencing tumor volume doubling time in hepatocellular carcinoma and its predictive value for progression-free survival. [PDF]

Sci Rep
Huang T, Chen Y.
europepmc   +1 more source

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study [PDF]

, 2012
François‐Clément Bidard, David Hajage, Thomas Bachelot, Suzette Delaloge, Étienne Brain, Mario Campone, Paul Cottu, Philippe Beuzeboc, Emilie Rolland, Claire Mathiot, Jean‐Yves Pierga   +10 more
openalex   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source